Stock Events

Stock Events

ENvue Medical 

0
102
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25FebExpected
Q4 0
Q3 2020
Q4 2025
-220
-219.67
-219.33
-219
Expected EPS
N/A
Actual EPS
N/A

Financials

-644.13%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.25MRevenue
-14.48MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation competes with NanoVibronix in the medical devices sector, focusing on products for various conditions that can overlap with NanoVibronix's pain management and wound healing solutions.
Medtronic
MDT
Mkt Cap120.46B
Medtronic plc offers a wide range of medical devices that compete directly with NanoVibronix's offerings, especially in the areas of pain management and therapeutic ultrasound technologies.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices segment, competes in the same space as NanoVibronix, offering products that can be used in wound care, surgery, and pain management.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation is a competitor due to its development and marketing of medical devices, including surgical equipment and orthopaedic devices that can be used in applications similar to NanoVibronix's.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. competes with NanoVibronix in the orthopaedic market, particularly in products related to bone healing, which may overlap with NanoVibronix's therapeutic ultrasound technology.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories offers medical devices across various segments, including cardiovascular and neuromodulation, competing with NanoVibronix's pain management solutions.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, which can be used in minimally invasive surgeries, a field where NanoVibronix's pain management and healing solutions could be applied.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences Corporation is a competitor in the field of patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, areas where NanoVibronix's technologies could be beneficial.

About

ENvue Medical Inc is a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings. It focuses on two technology platforms: the ENvue Navigation Platform, which provides an electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract; FDA 510(k) cleared for adult use, it provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure. Its Medical advances non-invasive therapy and minimally invasive navigation, with a commitment to patient safety, clinical usability, and technology innovation in healthcare environments, and the company's acoustic-based therapeutic technologies.
Show more...
CEO
Doron Robert Besser
Employees
14
Country
United States
ISIN
US63008J8844
WKN
000A42H0L

Listings

MU
DE
56R.MU
STU
DE
56R.STU
F
DE
56R.F
BOATS
BOATS
FEED.BOATS

0 Comments

Share your thoughts

FAQ

What is ENvue Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange ENvue Medical stocks are traded under the ticker 56R1.MU.
What is ENvue Medical revenue for the last year?▼
ENvue Medical revenue for the last year amounts to 2.25M EUR.
What is ENvue Medical net income for the last year?▼
56R1.MU net income for the last year is -14.48M EUR.
How many employees does ENvue Medical have?▼
As of September 10, 2026, the company has 14 employees.
In which sector is ENvue Medical located?▼
ENvue Medical operates in the Health & Wellness sector.
When did ENvue Medical complete a stock split?▼
The last stock split for ENvue Medical was on September 01, 2026 with a ratio of 1:12.
Where is ENvue Medical headquartered?▼
ENvue Medical is headquartered in TYLER, United States.